ARRY-797

CAS No. 1036404-17-7

ARRY-797( ARRY-371797 | ARRY-797 )

Catalog No. M28777 CAS No. 1036404-17-7

ARRY-797 is a potent and selective p38α inhibitor and inhibits LPS-Induced IL-6.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 131 Get Quote
10MG 218 Get Quote
25MG 385 Get Quote
50MG 655 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    ARRY-797
  • Note
    Research use only, not for human use.
  • Brief Description
    ARRY-797 is a potent and selective p38α inhibitor and inhibits LPS-Induced IL-6.
  • Description
    ARRY-797 is a potent and selective p38α inhibitor and inhibits LPS-Induced IL-6.(In Vivo):ARRY-797 inhibits the growth of RPMI-8226 Human Multiple Myeloma Cells. ARRY-371797 prevented left ventricular dilatation and deterioration of fractional shortening compared with placebo-treated mice.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ARRY-371797 | ARRY-797
  • Pathway
    Apoptosis
  • Target
    IL Receptor
  • Recptor
    Microtubule/Tubulin
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1036404-17-7
  • Formula Weight
    ——
  • Molecular Formula
    ——
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.An W, et al. Discovery of novel 2-phenyl-imidazo[1,2-a]pyridine analogues targeting tubulin polymerization as antiproliferative agents. Eur J Med Chem. 2016 Apr 13;112:367-372.
molnova catalog
related products
  • Procyanidin A2

    Procyanidin A2 is a potential precursor of 5-(3',4'-dihydroxyphenyl)-γ-valerolactone, exhibits antioxidant, anti-inflammary, anti-hyperglycemia, and anti-type 2 diabetes activities.

  • NFAT inhibitor, Cell...

    NFAT inhibitor. Inhibits LPS or LPS plus IFN-γ-induced IL-12 p40, IL-12 p70, IL-23 and TNF secretion from bone marrow-derived macrophages (BMDMs). Also attenuates NO production and Nos2 mRNA expression in LPS-stimulated BMDMs. Improves symptoms in a mouse model of colitis. Exhibits immunosuppressive effects; enhances graft survival in mice. Cell permeable.

  • Mepolizumab

    Mepolizumab is a humanized monoclonal antibody neutralizing IL-5. Mepolizumab can be used in studies about severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis.